Nearly a decade ago, federal health inspectors wanted to shut down the Framingham pharmacy linked to a recent deadly meningitis outbreak until it cleaned up its operations, according to congressional investigators.
Federal health inspectors found more than a dozen manufacturing problems, including leaky ceilings and insects, at Ameridose.
The state’s oversight of compounding pharmacies will be the subject of a legislative hearing.
A company spokesman says the notice affects 650 employees at Ameridose and 140 employees at its marketing and support arm.
The Director of the Massachusetts Board of Pharmacy has been fired amid an investigation into New England Compounding Center’s role in the nation-wide meningitis outbreak.
A company with the same founders as a specialty pharmacy tied to a deadly meningitis outbreak has agreed to extend its voluntary closure until Nov. 19.
A Massachusetts lawmaker says he’ll introduce legislation to increase federal oversight of specialty pharmacies like the one linked to a deadly meningitis outbreak.
A forensic pathologist says an autopsy shows a Kentucky judge’s death was linked to tainted steroid shots at a Tennessee clinic.
The compounding pharmacy in Framingham blamed for a national fungal meningitis outbreak reportedly sent customers a “quality assurance report card” just before people started getting sick.
The Department of Public Health has revoked the license of another compounding pharmacy in the state.